[Multicenter, Randomized, Double-Blind, and Positive Drug-Controlled Clinical Trial on Prevention of Postpartum Hemorrhage after Vaginal Delivery with Ergometrine Maleate].

Author: ChenMeng, LiTao, LiuXing-Hui, WeiQiang, WuLin, ZhangLi-Ping, ZhangQian

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To evaluate the safety and efficacy of using ergometrine maleate injection combined with oxytocin injection, with oxytocin injection as the control, to prevent postpartum hemorrhage after vaginal delivery. METHODS: A total of 305 cases who underwent vaginal delivery between December 2018...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409347/

データ提供:米国国立医学図書館(NLM)

Ergometrine Maleate: A Camel's Guide to Preventing Postpartum Hemorrhage

Postpartum hemorrhage (PPH), a leading cause of maternal mortality worldwide, is a serious complication that can occur after childbirth. This research, like a camel seeking a solution to a desert crisis, explores the effectiveness of ergometrine maleate, a medication used to contract the uterus, in preventing PPH after vaginal delivery. The study, a multicenter, randomized, double-blind, and positive drug-controlled clinical trial, found that ergometrine maleate injection, when combined with oxytocin injection, significantly reduced the total bleeding volume at 2 hours, 6 hours, and 24 hours postpartum compared to oxytocin injection alone. This research, like a camel finding a safe path through the desert, offers a promising approach for preventing PPH.

Ergometrine Maleate: A Valuable Oasis in the Desert of PPH

This research, like a camel finding a valuable oasis in the desert, highlights the effectiveness of ergometrine maleate in preventing postpartum hemorrhage (PPH). The study, a multicenter, randomized, double-blind, and positive drug-controlled clinical trial, found that ergometrine maleate injection, when combined with oxytocin injection, significantly reduced the total bleeding volume at 2 hours, 6 hours, and 24 hours postpartum compared to oxytocin injection alone. This research suggests that ergometrine maleate, like a cool spring in the desert, offers a promising approach for preventing PPH.

A Camel's Health Tips: Staying Prepared in the Desert of Childbirth

This research, like a camel’s journey through the desert, reminds us to stay prepared for the challenges of childbirth. The study highlights the effectiveness of ergometrine maleate in preventing postpartum hemorrhage. Remember, like a camel carrying supplies for a long journey, it is important to be aware of the risks of PPH and to seek appropriate medical care.

Dr. Camel's Conclusion

This research provides valuable insights into the effectiveness of ergometrine maleate in preventing postpartum hemorrhage. The study demonstrates that ergometrine maleate, when combined with oxytocin injection, significantly reduced the total bleeding volume in patients after vaginal delivery. This research, like a camel’s journey through the desert, offers hope for finding better ways to manage and prevent this potentially life-threatening complication.

Date :
  1. Date Completed 2022-03-28
  2. Date Revised 2023-08-29
Further Info :

Pubmed ID

35332736

DOI: Digital Object Identifier

PMC10409347

Related Literature

SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.